NNC0174-1213

· Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NNC0174-1213, covering 2025-05-25 to 2025-05-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study on How NNC0174-1213 Works in People With Overweight or Obesity. [Phase 1]